Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
NO is synthesized by eNOS in endothelial cells and diffuses to vascular smooth muscle, where it activates the cytosolic form of guanylate cyclase (also known as guanylyl cyclase) to form cyclic guanosine monophosphate (cGMP)
This mechanism is increasingly recognized as central to depression, anxiety, and cognitive decline
Studies using radiolabeled BPC-157 show that even when injected in a distant location, the peptide migrates to injured tissues throughout the body
US$ 29.32
US$ 28.08
US$ 28.28
US$ 24.27
US$ 29.05
